Covalent Modulation in Drug Discovery Conference

The Covalent Modulation in Drug Discovery Conference ended with a presentation by Ed Tate, who showcased a range of research projects from his group. A summary of the talk described it as a "firework" of covalent drug discovery work, and linked to a recent JACS article connected to the research. Attendees shared the presentation online as a highlight of the meeting.

The Covalent Modulation in Drug Discovery Conference has begun, opening with a talk by Matt Bilyard of Roche. He outlined how the company selects targets for covalent drug discovery and identifies and develops covalent binders. The presentation was described as insightful, with attendees sharing early reactions from the event online.